The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Nils Wierup

Nils Wierup

Senior lecturer

Nils Wierup

Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.

Author

  • Hedvig Bennet
  • Alexander Balhuizen
  • Anya Medina Benavente
  • Marloes Dekker Nitert
  • Emilia Ottosson Laakso
  • S Essén
  • Peter Spégel
  • Petter Storm
  • Ulrika Krus
  • Nils Wierup
  • Malin Fex

Summary, in English

Islet produced 5-hydroxy tryptamine (5-HT) is suggested to regulate islet hormone secretion in a paracrine and autocrine manner in rodents. Hitherto, no studies demonstrate a role for this amine in human islet function, nor is it known if 5-HT signaling is involved in the development of beta cell dysfunction in type 2 diabetes (T2D). To clarify this, we performed a complete transcriptional mapping of 5-HT receptors and processing enzymes in human islets and investigated differential expression of these genes in non-diabetic and T2D human islet donors. We show the expression of fourteen 5-HT receptors as well as processing enzymes involved in the biosynthesis of 5-HT at the mRNA level in human islets. Two 5-HT receptors (HTR1D and HTR2A) were over-expressed in T2D islet donors. Both receptors (5-HT1d and 5-HT2a) were localized to human alpha, beta and delta cells. 5-HT inhibited both insulin and glucagon secretion in non-diabetic islet donors. In islets isolated from T2D donors the amine significantly increased release of insulin in response to glucose. Our results suggest that 5-HT signaling participates in regulation of overall islet hormone secretion in non- diabetic individuals and over-expression of HTR1D and HTR2A may either contribute to islet dysfunction in T2D or arise as a consequence of an already dysfunctional islet.

Department/s

  • Celiac Disease and Diabetes Unit
  • Genomics, Diabetes and Endocrinology
  • Diabetes - Epigenetics
  • Department of Experimental Medical Science
  • Diabetes - Molecular Metabolism
  • Diabetes - Islet Patophysiology
  • Neuroendocrine Cell Biology
  • EXODIAB: Excellence of Diabetes Research in Sweden

Publishing year

2015

Language

English

Pages

113-120

Publication/Series

Peptides

Volume

71

Document type

Journal article

Publisher

Elsevier

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetes and Celiac Unit
  • Genomics, Diabetes and Endocrinology
  • Diabetes - Epigenetics
  • Diabetes - Molecular Metabolism
  • Diabetes - Islet Patophysiology
  • Neuroendocrine Cell Biology

ISBN/ISSN/Other

  • ISSN: 1873-5169